- Q4 2023 Fagron NV Earnings Call TranscriptFeb 15, 2024€17.91 (+2.52%)Earnings
- Q3 2023 Fagron NV Trading Statement Call TranscriptOct 12, 2023
- Q2 2023 Fagron NV Earnings Call TranscriptAug 03, 2023€16.08 (+0.75%)Earnings
- Q1 2023 Fagron NV Trading Statement Call TranscriptApr 13, 2023
- Q4 2022 Fagron NV Earnings Call TranscriptFeb 09, 2023€15.1 (+15.71%)Earnings
- Q3 2022 Fagron NV Trading Statement Call TranscriptOct 13, 2022
- Q2 2022 Fagron NV Earnings Call TranscriptAug 04, 2022€13.91 (-7.64%)Earnings
- Q1 2022 Fagron NV Trading Statement Call TranscriptApr 14, 2022
- Fagron NV At Capital Markets Day TranscriptMar 15, 2022
- Q4 2021 Fagron NV Earnings Presentation TranscriptFeb 10, 2022
- Q3 2021 Fagron NV Trading Statement Call TranscriptOct 13, 2021
- Q2 2021 Fagron NV Earnings Call TranscriptAug 05, 2021€18.38 (+3.84%)Earnings
- Q4 2020 Fagron NV Earnings Call TranscriptFeb 11, 2021€20.42 (-2.67%)Earnings
- Half Year 2020 Fagron NV Earnings Call TranscriptAug 06, 2020€19.2 (+3.67%)Earnings
- Q1 2020 Fagron NV Earnings Call TranscriptApr 14, 2020€19.51 (+8.33%)Earnings
- Full Year 2019 Fagron NV Earnings Call TranscriptFeb 13, 2020€22.68 (-1.82%)Earnings
- Q3 2019 Fagron NV Corporate Sales Call TranscriptOct 11, 2019
- Q2 2019 Fagron NV Earnings Call TranscriptAug 05, 2019€15.75 (+5.70%)Earnings
- Q1 2019 Fagron NV Corporate Sales Call TranscriptApr 12, 2019
Q1 2022 Fagron NV Trading Statement Call Transcript
Hello, and welcome to the Fagron trading update Q1 2022. Please note, this conference is being recorded. (Operator Instructions) I will now hand over to your host, Karen Berg, to begin today's conference. Thank you.
Thank you, and Good morning, everyone. Welcome to the presentation of our first quarter 2022 trading update. I'm here together with our CEO, Rafael Padilla; and our CFO, Karin de Jong. Rafael will start with a discussion of the business development, and then Karin will discuss the financial development, and then we will open the line for questions. Well, thank you for that. And I would like to hand over to Rafael.
Thank you very much, Karen, and thank you all for joining us into this Q1 conference call. We start always with our purpose as we are a culture-driven company. Together, we create the future of personalizing medicine. Personalizing medicine is the future. And pharmaceutical compounding mix is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)